249 related articles for article (PubMed ID: 25788268)
21. PKCδ mediates mitochondrial ROS generation and oxidation of HSP60 to relieve RKIP inhibition on MAPK pathway for HCC progression.
Mandal JP; Shiue CN; Chen YC; Lee MC; Yang HH; Chang HH; Hu CT; Liao PC; Hui LC; You RI; Wu WS
Free Radic Biol Med; 2021 Feb; 163():69-87. PubMed ID: 33307168
[TBL] [Abstract][Full Text] [Related]
22. COLEC10 Induces Endoplasmic Reticulum Stress by Occupying GRP78 and Inhibits Hepatocellular Carcinoma.
Cai MN; Chen DM; Xiao LX; Li SS; Liao CH; Li J; Huang ZX; Wang JL; Gu YR; Gu L; Huang YH; Lian YF
Lab Invest; 2023 Jul; 103(7):100130. PubMed ID: 36925047
[TBL] [Abstract][Full Text] [Related]
23. Piperlongumine inhibits head and neck squamous cell carcinoma proliferation by docking to Akt.
Lv F; Deng M; Bai J; Zou D; Wang J; Li H; Zhang Y; Ji X
Phytother Res; 2020 Dec; 34(12):3345-3358. PubMed ID: 32798277
[TBL] [Abstract][Full Text] [Related]
24. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems.
Wang H; Jiang H; Corbet C; de Mey S; Law K; Gevaert T; Feron O; De Ridder M
Cancer Lett; 2019 May; 450():42-52. PubMed ID: 30790679
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma.
Li X; Pan YF; Chen YB; Wan QQ; Lin YK; Shang TY; Xu MY; Jiang TY; Pei MM; Tan YX; Dong LW; Wan XY
Cell Death Dis; 2024 Apr; 15(4):300. PubMed ID: 38684648
[TBL] [Abstract][Full Text] [Related]
26. Piperlongumine inhibits angiotensin II-induced extracellular matrix expression in cardiac fibroblasts.
Wu X; Liu Y; An J; Li J; Lv W; Geng S; Zhang Y
J Cell Biochem; 2018 Dec; 119(12):10358-10364. PubMed ID: 30145839
[TBL] [Abstract][Full Text] [Related]
27. Thymoquinone Potentiated the Anticancer Effect of Cisplatin on Hepatic Tumorigenesis by Modulating Tissue Oxidative Stress and Endoplasmic GRP78/CHOP Signaling.
Farghaly ME; Khowailed AA; Aboulhoda BE; Rashed LA; Gaber SS; Ashour H
Nutr Cancer; 2022; 74(1):278-287. PubMed ID: 33533291
[TBL] [Abstract][Full Text] [Related]
28. Integrating network pharmacology and experimental models to examine the mechanisms of corosolic acid in preventing hepatocellular carcinoma progression through activation PERK-eIF2a-ATF4 signaling.
Tang F; Peng Y; Liu J; Gao W; Xu Y
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3671-3682. PubMed ID: 37294427
[TBL] [Abstract][Full Text] [Related]
29. ARHGEF2/EDN1 pathway participates in ER stress-related drug resistance of hepatocellular carcinoma by promoting angiogenesis and malignant proliferation.
Zhu Y; Liu W; Wang Z; Wang Y; Tan C; Pan Z; Wang A; Liu J; Sun G
Cell Death Dis; 2022 Jul; 13(7):652. PubMed ID: 35896520
[TBL] [Abstract][Full Text] [Related]
30. Increased Expression of FosB through Reactive Oxygen Species Accumulation Functions as Pro-Apoptotic Protein in Piperlongumine Treated MCF7 Breast Cancer Cells.
Park JA; Na HH; Jin HO; Kim KC
Mol Cells; 2019 Dec; 42(12):884-892. PubMed ID: 31735020
[TBL] [Abstract][Full Text] [Related]
31. Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma.
Jain D; Murti Y; Khan WU; Hossain R; Hossain MN; Agrawal KK; Ashraf RA; Islam MT; Janmeda P; Taheri Y; Alshehri MM; Daştan SD; Yeskaliyeva B; Kipchakbayeva A; Sharifi-Rad J; Cho WC
Oxid Med Cell Longev; 2021; 2021():9068850. PubMed ID: 34754365
[TBL] [Abstract][Full Text] [Related]
32. Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer.
Zheng L; Fang S; Chen A; Chen W; Qiao E; Chen M; Shu G; Zhang D; Kong C; Weng Q; Xu S; Zhao Z; Ji J
Pharmacol Res; 2022 Mar; 177():106140. PubMed ID: 35202819
[TBL] [Abstract][Full Text] [Related]
33. Piperlongumine and bortezomib synergically inhibit cholangiocarcinoma via ER stress-induced cell death.
Naradun N; Talabnin K; Ayuttha KIN; Talabnin C
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jan; 396(1):109-120. PubMed ID: 36227332
[TBL] [Abstract][Full Text] [Related]
34. Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway.
Guo M; Wang W; Bai W; Bai Z; Chen W; Su Y; Wu J
Can J Gastroenterol Hepatol; 2022; 2022():6413783. PubMed ID: 36262827
[TBL] [Abstract][Full Text] [Related]
35. Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells.
Rawat L; Hegde H; Hoti SL; Nayak V
Biomed Pharmacother; 2020 Aug; 128():110243. PubMed ID: 32470748
[TBL] [Abstract][Full Text] [Related]
36. Human β-defensin 1 Functions as a Tumor Suppressor via ER Stress-triggered JNK pathway in Hepatocellular Carcinoma.
Li X; Song W; Zhang M; Zhao P
J BUON; 2021; 26(4):1365-1372. PubMed ID: 34564993
[TBL] [Abstract][Full Text] [Related]
37. A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma.
Qian J; Xu Z; Zhu P; Meng C; Liu Y; Shan W; He A; Gu Y; Ran F; Zhang Y; Ling Y
J Nat Prod; 2021 Dec; 84(12):3161-3168. PubMed ID: 34806369
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of Low-density lipoprotein receptor-related protein 1B (LRP1B) inhibits the progression of hepatocellular carcinoma cells by activating the endoplasmic reticulum stress signaling pathway.
Zhen Z; Shen Z; Sun P
Bioengineered; 2022 Apr; 13(4):9467-9481. PubMed ID: 35389768
[TBL] [Abstract][Full Text] [Related]
39. Antineoplastic influence of nimesulide in chemically induced hepatocellular carcinoma by inhibition of DNA synthesis.
Afzal M; Bhardwaj DP; Khan R; Kazmi I; Saleem S; Al-Abbasi FA; Anwar F
Inflammopharmacology; 2019 Feb; 27(1):89-98. PubMed ID: 29728874
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy.
Mahameed M; Boukeileh S; Obiedat A; Darawshi O; Dipta P; Rimon A; McLennan G; Fassler R; Reichmann D; Karni R; Preisinger C; Wilhelm T; Huber M; Tirosh B
Nat Commun; 2020 Mar; 11(1):1304. PubMed ID: 32161259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
